Unprecedented

To all the fresh eyes tempted by the ridiculously cheap CUV...
All available Clinuvel forums have been overwhelmed with negativity. New posters swarming with the same message about doom and gloom. Certainly the last 3 years have been an awful time to be invested, so their words resonate with the doubters. A large fund has controlled the action with 3.5 million "shorted" shares to suppress the price. Why? Who knows. Creating a hopeless narrative? Cheap takeover? Squashing a game changing drug that could wreck multiple industries? All possible, and worthy of concern.
PW, Sean Parker, Rosenfeld, Grimes etc. are a step ahead and ready to unleash afamelanotide to the world.

Here's the deal...
Top line will approach $100 million in 2025.
Profits will again grow in the neighborhood of 15% and close in on $1 per share.
Clinuvel has zero debt. Not $1.
Clinuvel is approaching $200,000,000 in cash...about $4 per share.
Back out the cash and the P/E is about 10.
Clinuvel is a monopoly, with no competition for several more years, if ever.
*Millions of vitiligo sufferers are close to a permanent solution.
*The holy grail of cosmetics is sun free natural tan option which will be unveiled soon.

*Even if the last two are forward looking statements with no guarantees, it remains undervalued based on EPP alone. The pipeline further out is even more exciting.
If these come to fruition, the sky is the limit and the market cap will be measured with 11 digits. Place your bets. And remember to question the so called longs that rip the company at every turn. Why wouldn't they just sell and move on? Rhetorical, they are not long.
Best of luck. DYOR.